Trendlines Group, an Israeli medical device incubator, says it paid an unspecified amount to acquire patents covering prostate cancer diagnosis and treatment it co-developed with Endo Health.
An Israeli medical device incubator said it paid an unspecified amount for the R&D product it co-developed with Endo Health Solutions (NSDQ:ENDP).
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uJz9oh
Cap comentari:
Publica un comentari a l'entrada